In the BioHarmony Drug Report Database

"Preview" Icon

Zafirlukast

Accolate (zafirlukast) is a small molecule pharmaceutical. Zafirlukast was first approved as Accolate on 1996-09-26. It is used to treat asthma in the USA. The pharmaceutical is active against cysteinyl leukotriene receptor 1. In addition, it is known to target cysteinyl leukotriene receptor 2, bifunctional epoxide hydrolase 2, and peroxisome proliferator-activated receptor gamma.

 

Trade Name

 

Accolate
 

Common Name

 

zafirlukast
 

ChEMBL ID

 

CHEMBL603
 

Indication

 

asthma
 

Drug Class

 

Antiasthmatics/antiallergics: leukotriene receptor antagonists

Image (chem structure or protein)

Zafirlukast structure rendering